{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:44Z","timestamp":1707524084371},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,6]]},"DOI":"10.7759\/cureus.9586","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:12:40Z","timestamp":1596715960000},"source":"Crossref","is-referenced-by-count":1,"title":["Sunitinib: An Unusual Cause of Pneumothorax in a Patient With Metastatic Chromophobe Renal Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Nedal","family":"Bukhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suha","family":"Al-Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"AlNaimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Azam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm408","article-title":"A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities","volume":"18","author":"Christensen JG","year":"2007","unstructured":"Christensen JG. A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities. Ann Oncol. 2007, 18:10. 10.1093\/annonc\/mdm408","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"11","author":"Motzer RJ","year":"2007","unstructured":"Motzer RJ, Hutson TE, Tomczak P, et al.. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007, 11:115-124. 10.1056\/NEJMoa065044","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00515-X","article-title":"Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial","volume":"17","author":"Armstrong AJ","year":"2016","unstructured":"Armstrong AJ, Halabi S, Eisen T, et al.. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Lancet Oncol. 2016, 17:378-388. 10.1016\/S1470-2045(15)00515-X","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4519","article-title":"Case: secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma","volume":"11","author":"Bukhari N","year":"2017","unstructured":"Bukhari N, Winquist E. Case: secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Can Urol Assoc J. 2017, 11:E449-E450. 10.5489\/cuaj.4519","journal-title":"Can Urol Assoc J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1291-3","article-title":"Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy","volume":"66","author":"Katta A","year":"2010","unstructured":"Katta A, Fesler MJ, Tan A, Vuong G, Richart JM. Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy. Cancer Chemother Pharmacol. 2010, 66:409-412. 10.1007\/s00280-010-1291-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref6","article-title":"Spontaneous pneumothorax complicating sunitinib therapy","volume":"15","author":"Kleontas A","year":"2011","unstructured":"Kleontas A, Asteriou Ch, Lalountas M, Konstantinou E, Barbetakis N. Spontaneous pneumothorax complicating sunitinib therapy. Hippokratia. 2011, 15:281-282.","journal-title":"Hippokratia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay J","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127:2893-2917. 10.1002\/ijc.25516","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/path.2689","article-title":"VHL and HIF signalling in renal cell carcinogenesis","volume":"221","author":"Baldewijns MM","year":"2010","unstructured":"Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bru\u00efne AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010, 221:125-138. 10.1002\/path.2689","journal-title":"J Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nm1337","article-title":"Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer","volume":"12","author":"Thomas GV","year":"2006","unstructured":"Thomas GV, Tran C, Mellinghoff IK, et al.. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med. 2006, 12:122-127. 10.1038\/nm1337","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318168c7e9","article-title":"Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer","volume":"3","author":"Marom EM","year":"2008","unstructured":"Marom EM, Martinez CH, Truong MT, et al.. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol. 2008, 3:351-357. 10.1097\/JTO.0b013e318168c7e9","journal-title":"J Thorac Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.07.01","article-title":"Influence and mechanism of lung cavitation development on antiangiogenic therapy","volume":"8","author":"Jiang M","year":"2019","unstructured":"Jiang M, Zhang C, Liu D, et al.. Influence and mechanism of lung cavitation development on antiangiogenic therapy. Transl Lung Cancer Res. 2019, 8:500-512. 10.21037\/tlcr.2019.07.01","journal-title":"Transl Lung Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5377","article-title":"Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition","volume":"10","author":"Hauben M","year":"2013","unstructured":"Hauben M, Hung EY. Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition. Int J Med Sci. 2013, 10:965-973. 10.7150\/ijms.5377","journal-title":"Int J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-4-14","article-title":"Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series","volume":"4","author":"Verschoor AJ","year":"2014","unstructured":"Verschoor AJ, Gelderblom H. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series. Clin Sarcoma Res. 2014, 4:14. 10.1186\/2045-3329-4-14","journal-title":"Clin Sarcoma Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/390702","article-title":"Axitinib induced recurrent pneumothorax following near-complete response of renal cell carcinoma lung metastasis: an unexpected complication","volume":"2012","author":"Socola F","year":"2012","unstructured":"Socola F, Loaiza-Bonilla A, Benedetto P. Axitinib induced recurrent pneumothorax following near-complete response of renal cell carcinoma lung metastasis: an unexpected complication. Case Rep Oncol Med. 2012, 2012:390702. 10.1155\/2012\/390702","journal-title":"Case Rep Oncol Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.0130","article-title":"Spontaneous pneumothorax in metastatic thyroid papillary carcinoma","volume":"25","author":"Lee MJ","year":"2007","unstructured":"Lee MJ, Kim EK, Kim MJ, Kwak JY, Hong S, Park CS. Spontaneous pneumothorax in metastatic thyroid papillary carcinoma. J Clin Oncol. 2007, 25:2616-2618. 10.1200\/JCO.2007.11.0130","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37584-sunitinib-an-unusual-cause-of-pneumothorax-in-a-patient-with-metastatic-chromophobe-renal-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:10Z","timestamp":1707506650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37584-sunitinib-an-unusual-cause-of-pneumothorax-in-a-patient-with-metastatic-chromophobe-renal-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.9586","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}